NCT02811523View on ClinicalTrials.gov

In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Bone SarcomaSoft Tissue SarcomaPulmonary Metastases
Interventions
DRUG

Doxorubicin

Doxorubicin by In Vivo Lung Perfusion

Trial Locations (1)

Unknown

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER